寿仙谷: 寿仙谷第五届董事会第二次会议决议公告

Meeting Overview - The second meeting of the fifth board of directors of Zhejiang Shouxiangu Pharmaceutical Co., Ltd. was held on August 27, 2025, in accordance with the Company Law and the Articles of Association [1] Financial Reporting - The board approved the 2025 semi-annual report, which complies with the relevant regulations and is accurate and complete [2] - The voting results for the semi-annual report were unanimous with 9 votes in favor, 0 against, and 0 abstentions [2] Fund Management - The board approved the special report on the storage and actual use of raised funds for the first half of 2025, confirming compliance with regulations and accurate disclosure [2] - The voting results for the fund management report were also unanimous with 9 votes in favor, 0 against, and 0 abstentions [2] Related Party Transactions - The board approved the proposal to increase the estimated amount of daily related party transactions for 2025, specifically raising the deposit limit with Wuyi Rural Commercial Bank to 550 million yuan [3][4] - The voting results for this proposal were 6 votes in favor, 0 against, and 0 abstentions, with certain directors abstaining from voting [3] Corporate Governance Changes - The board approved a proposal to change the company's registered capital and abolish the supervisory board, transferring its responsibilities to the audit committee [4] - The registered capital was adjusted from 198,241,889 yuan to 198,243,911 yuan due to the conversion of bonds [4] - The proposal to amend the Articles of Association was also approved with unanimous support [4] Upcoming Shareholder Meeting - The company plans to hold its first extraordinary general meeting of 2025 on September 18, 2025, in accordance with the Company Law and Articles of Association [5] - The voting results for the meeting proposal were unanimous with 9 votes in favor, 0 against, and 0 abstentions [5]